Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue concerns the development of a theory for energy conversion on the nanoscale, namely, nanothermodynamics. The theory has been applied to porous media, small surfaces, clusters or fluids under confinement. The number of unsolved issues in these contexts is numerous and the present efforts are only painting part of the broader picture. We attempt to answer the following: How far down in scale does the Gibbs equation apply? Which theory can replace it beyond the thermodynamic limit? It is well known that confinement changes the equation of state of a fluid, but how does confinement change the equilibrium conditions themselves? This Special Issue explores some of the roads that were opened up for us by Hill with the idea of nanothermodynamics. The experimental progress in nanotechnology is advancing rapidly. It is our ambition with this book to inspire an increased effort in the development of suitable theoretical tools and methods to help further progress in nanoscience. All ten contributions to this Special Issue can be seen as efforts to support, enhance and validate the theoretical foundation of Hill.

Technology: general issues --- nanothermodynamics --- porous systems --- molecular simulation --- differential pressure --- integral pressure --- pressure --- confinement --- equilibrium --- thermodynamic --- small-system --- hills-thermodynamics --- pore --- nanopore --- interface --- Kirkwood-Buff integrals --- surface effects --- molecular dynamics --- activated carbon --- high-pressure methane adsorption --- thermodynamics of adsorption systems --- small system method --- thermodynamics of small systems --- hydration shell thermodynamics --- finite size correction --- adsorption --- thin film --- size-dependent --- thermodynamics --- spreading pressure --- entropy of adsorption --- polymers --- single-molecule stretching --- thermodynamics at strong coupling --- temperature-dependent energy levels --- Hill’s thermodynamics of small systems --- porous media --- statistical mechanics --- ideal gas --- nanoparticles --- n/a --- Hill's thermodynamics of small systems

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Molecular simulations are commonly used in physics, chemistry, biology, material science, engineering, and even medicine. This book provides a wide range of molecular simulation methods and their applications in various fields. It reflects the power of molecular simulation as an effective research tool. We hope that the presented results can provide an impetus for further fruitful studies.

Technology. --- molecular dynamics simulation --- osmosis --- water transport --- nanochannel --- carbon nanotube --- graphene --- osmolyte --- compartment --- rhodopsins --- spectral properties of rhodopsins --- spectral tuning in rhodopsins --- engineering of red-shifted rhodopsins --- photobiology --- biological photosensors --- molecular modeling --- multiscale --- coarse graining --- Monte Carlo simulation --- force fields --- neural network --- many body interactions --- sampling --- local sampling --- local free energy landscape --- generalized solvation free energy --- molecular solvation theory --- three-dimensional reference interaction site model --- Kovalenko-Hirata closure --- biomolecular simulation --- multiple time step MD --- protein-ligand binding --- biomolecular solvation --- antibody --- epitope --- molecular dynamics --- mutation --- toll-like receptor --- GPU programming --- DNA damage --- proton transport --- drag reduction --- surfactant molecules --- self-assembly --- coarse-grained molecular simulation --- numerical method --- laser-matter interaction --- time-dependent Schrödinger equation --- time-dependent unitary transformation method --- strong-field ionization --- Kramers-Henneberger frame --- hairy nanoparticles --- adsorption on nanoparticles --- nanocarriers --- computer simulations --- COVID-19 --- SARS-CoV-2 --- PF-07321332 --- α-ketoamide --- 3CL protease --- main protease --- DFT --- CASTEP --- aiMD --- ab initio molecular dynamics --- phase transition --- polymorphism --- Janus particles --- phase transitions --- gemini --- force field --- parametrisation --- antimicrobial --- membranes --- colloids with competing interactions --- periodic microphases --- confinement --- Monte Carlo --- atomistic simulation --- molecular simulation --- hard sphere --- extreme conditions --- nanocomposites --- cluster --- crystallization --- atomic structure --- packing --- semi-flexible polymers --- order parameter --- molecular dynamics simulation --- osmosis --- water transport --- nanochannel --- carbon nanotube --- graphene --- osmolyte --- compartment --- rhodopsins --- spectral properties of rhodopsins --- spectral tuning in rhodopsins --- engineering of red-shifted rhodopsins --- photobiology --- biological photosensors --- molecular modeling --- multiscale --- coarse graining --- Monte Carlo simulation --- force fields --- neural network --- many body interactions --- sampling --- local sampling --- local free energy landscape --- generalized solvation free energy --- molecular solvation theory --- three-dimensional reference interaction site model --- Kovalenko-Hirata closure --- biomolecular simulation --- multiple time step MD --- protein-ligand binding --- biomolecular solvation --- antibody --- epitope --- molecular dynamics --- mutation --- toll-like receptor --- GPU programming --- DNA damage --- proton transport --- drag reduction --- surfactant molecules --- self-assembly --- coarse-grained molecular simulation --- numerical method --- laser-matter interaction --- time-dependent Schrödinger equation --- time-dependent unitary transformation method --- strong-field ionization --- Kramers-Henneberger frame --- hairy nanoparticles --- adsorption on nanoparticles --- nanocarriers --- computer simulations --- COVID-19 --- SARS-CoV-2 --- PF-07321332 --- α-ketoamide --- 3CL protease --- main protease --- DFT --- CASTEP --- aiMD --- ab initio molecular dynamics --- phase transition --- polymorphism --- Janus particles --- phase transitions --- gemini --- force field --- parametrisation --- antimicrobial --- membranes --- colloids with competing interactions --- periodic microphases --- confinement --- Monte Carlo --- atomistic simulation --- molecular simulation --- hard sphere --- extreme conditions --- nanocomposites --- cluster --- crystallization --- atomic structure --- packing --- semi-flexible polymers --- order parameter

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Molecular simulations are commonly used in physics, chemistry, biology, material science, engineering, and even medicine. This book provides a wide range of molecular simulation methods and their applications in various fields. It reflects the power of molecular simulation as an effective research tool. We hope that the presented results can provide an impetus for further fruitful studies.

molecular dynamics simulation --- osmosis --- water transport --- nanochannel --- carbon nanotube --- graphene --- osmolyte --- compartment --- rhodopsins --- spectral properties of rhodopsins --- spectral tuning in rhodopsins --- engineering of red-shifted rhodopsins --- photobiology --- biological photosensors --- molecular modeling --- multiscale --- coarse graining --- Monte Carlo simulation --- force fields --- neural network --- many body interactions --- sampling --- local sampling --- local free energy landscape --- generalized solvation free energy --- molecular solvation theory --- three-dimensional reference interaction site model --- Kovalenko-Hirata closure --- biomolecular simulation --- multiple time step MD --- protein-ligand binding --- biomolecular solvation --- antibody --- epitope --- molecular dynamics --- mutation --- toll-like receptor --- GPU programming --- DNA damage --- proton transport --- drag reduction --- surfactant molecules --- self-assembly --- coarse-grained molecular simulation --- numerical method --- laser-matter interaction --- time-dependent Schrödinger equation --- time-dependent unitary transformation method --- strong-field ionization --- Kramers-Henneberger frame --- hairy nanoparticles --- adsorption on nanoparticles --- nanocarriers --- computer simulations --- COVID-19 --- SARS-CoV-2 --- PF-07321332 --- α-ketoamide --- 3CL protease --- main protease --- DFT --- CASTEP --- aiMD --- ab initio molecular dynamics --- phase transition --- polymorphism --- Janus particles --- phase transitions --- gemini --- force field --- parametrisation --- antimicrobial --- membranes --- colloids with competing interactions --- periodic microphases --- confinement --- Monte Carlo --- atomistic simulation --- molecular simulation --- hard sphere --- extreme conditions --- nanocomposites --- cluster --- crystallization --- atomic structure --- packing --- semi-flexible polymers --- order parameter --- n/a --- time-dependent Schrödinger equation --- Technology.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book is a printed edition of the Special Issue entitled “Anticancer Agents: Design, Synthesis and Evaluation” that was published in Molecules. Two review articles and thirty research papers are included in the Special Issue. Three second-generation androgen receptor antagonists that have been approved by the U.S. FDA for the treatment of prostate cancer have been reviewed. Identification of mimics of protein partners as protein-protein interaction inhibitors via virtual screening has been summarized and discussed. Anticancer agents targeting various protein targets, including IGF-1R, Src, protein kinase, aromatase, HDAC, PARP, Toll-Like receptor, c-Met, PI3Kdelta, topoisomerase II, p53, and indoleamine 2,3-dioxygenase, have been explored. The analogs of three well-known tubulin-interacting natural products, paclitaxel, zampanolide, and colchicine, have been designed, synthesized, and evaluated. Several anticancer agents representing diverse chemical scaffolds were assessed in different kinds of cancer cell models. The capability of some anticancer agents to overcome the resistance to currently available drugs was also studied. In addition to looking into the in vitro ability of the anticancer agents to inhibit cancer cell proliferation, apoptosis, and cell cycle, in vivo antitumor efficacy in animal models and DFT were also investigated in some papers.

Medicine --- benzofurans --- chemical synthesis --- cytotoxic properties --- HeLa --- MOLT-4 --- K562 --- anticancer --- anti-neuroinflammation --- coumarin --- dihydroartemisinin --- flavonoids --- allene --- E-stereoselective --- regioselective --- anti-cancer activity --- cyanopyridone --- substituted pyridine --- pyridotriazine --- pyrazolopyridine --- thioxotriazopyridine --- anticancer activity --- HepG2 --- antitumor activity --- computational docking --- MDM2-p53 interaction --- xanthones --- yeast-based assays --- estrone derivatives --- hydrazine --- N-substituted pyrazoline --- anti-ovarian cancer --- topoisomerase II inhibitor --- kinase inhibitor --- antiproliferative agent --- urea --- synthesis --- antiproliferative activity --- apoptosis --- indoleamine 2,3-dioxygenase --- inhibitor --- anti-tumor --- immune modulation --- tryptophan metabolism --- taxoids --- βIII-tubulin --- P-glycoprotein --- drug resistance --- thiopene --- thienopyrimidinone --- thiazolidinone --- breast cancer --- benzofuran–pyrazole --- nanoparticles --- cytotoxic activity --- PARP-1 inhibition --- 3,6-dibromocarbazole --- 5-bromoindole --- carbazole --- actin --- migration --- Thienopyrimidine --- Pyrazole --- PI3Kα inhibitor --- quinazolin-4(3H)-one --- quinazolin-4(3H)-thione --- Schiff base --- antioxidant activity --- DFT study --- ortho-quinones --- beta-lapachone --- tanshione IIA --- PI3Ks --- PI3Kδ inhibitors --- 2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide --- anticancer agents --- protein–protein interactions --- virtual screening --- mimetics --- drug discovery --- bivalency --- polyvalency --- antitumor --- cell cycle --- ovarian cancer --- P-MAPA --- IL-12 --- TLR signaling --- inflammation --- chemoresistance --- 4-(pyridin-4-yloxy)benzamide --- 1,2,3-triazole --- c-Met --- natural product --- anticancer agent --- zampanolide --- Talazoparib --- PARP inhibitor --- prodrug --- o-nitro-benzyl --- photoactivatable protecting groups --- salinomycin --- overcoming drug resistance --- tumor specificity --- synergy --- 5-fluorouracil --- gemcitabine --- amides/esters --- colchicine analogs --- thiocolchicine --- colchiceine --- antimitotic agents --- hydrates --- dihydropyranoindole --- HDAC inhibitors --- neuroblastoma --- aromatase --- MCF-7 --- NIH3T3 --- benzimidazole --- triazolothiadiazine --- docking --- ADME --- organosilicon compounds --- SILA-409 (Alis-409) --- SILA-421 (Alis-421) --- multidrug resistance (MDR) reversal --- ABCB1 (P-glycoprotein) --- colon cancer --- colchicine amide --- colchicine sulfonamide --- tubulin inhibitors --- docking studies --- crystal structure --- PROTACs --- protein degradation --- IGF-1R --- Src --- protein kinase --- phenylpyrazolopyrimidine --- enzyme inhibition --- molecular simulation --- androgen receptor --- prostate cancer --- enzalutamide --- apalutamide --- darolutamide --- triple-negative breast cancer --- cytotoxicity --- chrysin analogues --- flavonoid --- anticancer compounds --- benzofurans --- chemical synthesis --- cytotoxic properties --- HeLa --- MOLT-4 --- K562 --- anticancer --- anti-neuroinflammation --- coumarin --- dihydroartemisinin --- flavonoids --- allene --- E-stereoselective --- regioselective --- anti-cancer activity --- cyanopyridone --- substituted pyridine --- pyridotriazine --- pyrazolopyridine --- thioxotriazopyridine --- anticancer activity --- HepG2 --- antitumor activity --- computational docking --- MDM2-p53 interaction --- xanthones --- yeast-based assays --- estrone derivatives --- hydrazine --- N-substituted pyrazoline --- anti-ovarian cancer --- topoisomerase II inhibitor --- kinase inhibitor --- antiproliferative agent --- urea --- synthesis --- antiproliferative activity --- apoptosis --- indoleamine 2,3-dioxygenase --- inhibitor --- anti-tumor --- immune modulation --- tryptophan metabolism --- taxoids --- βIII-tubulin --- P-glycoprotein --- drug resistance --- thiopene --- thienopyrimidinone --- thiazolidinone --- breast cancer --- benzofuran–pyrazole --- nanoparticles --- cytotoxic activity --- PARP-1 inhibition --- 3,6-dibromocarbazole --- 5-bromoindole --- carbazole --- actin --- migration --- Thienopyrimidine --- Pyrazole --- PI3Kα inhibitor --- quinazolin-4(3H)-one --- quinazolin-4(3H)-thione --- Schiff base --- antioxidant activity --- DFT study --- ortho-quinones --- beta-lapachone --- tanshione IIA --- PI3Ks --- PI3Kδ inhibitors --- 2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide --- anticancer agents --- protein–protein interactions --- virtual screening --- mimetics --- drug discovery --- bivalency --- polyvalency --- antitumor --- cell cycle --- ovarian cancer --- P-MAPA --- IL-12 --- TLR signaling --- inflammation --- chemoresistance --- 4-(pyridin-4-yloxy)benzamide --- 1,2,3-triazole --- c-Met --- natural product --- anticancer agent --- zampanolide --- Talazoparib --- PARP inhibitor --- prodrug --- o-nitro-benzyl --- photoactivatable protecting groups --- salinomycin --- overcoming drug resistance --- tumor specificity --- synergy --- 5-fluorouracil --- gemcitabine --- amides/esters --- colchicine analogs --- thiocolchicine --- colchiceine --- antimitotic agents --- hydrates --- dihydropyranoindole --- HDAC inhibitors --- neuroblastoma --- aromatase --- MCF-7 --- NIH3T3 --- benzimidazole --- triazolothiadiazine --- docking --- ADME --- organosilicon compounds --- SILA-409 (Alis-409) --- SILA-421 (Alis-421) --- multidrug resistance (MDR) reversal --- ABCB1 (P-glycoprotein) --- colon cancer --- colchicine amide --- colchicine sulfonamide --- tubulin inhibitors --- docking studies --- crystal structure --- PROTACs --- protein degradation --- IGF-1R --- Src --- protein kinase --- phenylpyrazolopyrimidine --- enzyme inhibition --- molecular simulation --- androgen receptor --- prostate cancer --- enzalutamide --- apalutamide --- darolutamide --- triple-negative breast cancer --- cytotoxicity --- chrysin analogues --- flavonoid --- anticancer compounds

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book is a printed edition of the Special Issue entitled “Anticancer Agents: Design, Synthesis and Evaluation” that was published in Molecules. Two review articles and thirty research papers are included in the Special Issue. Three second-generation androgen receptor antagonists that have been approved by the U.S. FDA for the treatment of prostate cancer have been reviewed. Identification of mimics of protein partners as protein-protein interaction inhibitors via virtual screening has been summarized and discussed. Anticancer agents targeting various protein targets, including IGF-1R, Src, protein kinase, aromatase, HDAC, PARP, Toll-Like receptor, c-Met, PI3Kdelta, topoisomerase II, p53, and indoleamine 2,3-dioxygenase, have been explored. The analogs of three well-known tubulin-interacting natural products, paclitaxel, zampanolide, and colchicine, have been designed, synthesized, and evaluated. Several anticancer agents representing diverse chemical scaffolds were assessed in different kinds of cancer cell models. The capability of some anticancer agents to overcome the resistance to currently available drugs was also studied. In addition to looking into the in vitro ability of the anticancer agents to inhibit cancer cell proliferation, apoptosis, and cell cycle, in vivo antitumor efficacy in animal models and DFT were also investigated in some papers.

benzofurans --- chemical synthesis --- cytotoxic properties --- HeLa --- MOLT-4 --- K562 --- anticancer --- anti-neuroinflammation --- coumarin --- dihydroartemisinin --- flavonoids --- allene --- E-stereoselective --- regioselective --- anti-cancer activity --- cyanopyridone --- substituted pyridine --- pyridotriazine --- pyrazolopyridine --- thioxotriazopyridine --- anticancer activity --- HepG2 --- antitumor activity --- computational docking --- MDM2-p53 interaction --- xanthones --- yeast-based assays --- estrone derivatives --- hydrazine --- N-substituted pyrazoline --- anti-ovarian cancer --- topoisomerase II inhibitor --- kinase inhibitor --- antiproliferative agent --- urea --- synthesis --- antiproliferative activity --- apoptosis --- indoleamine 2,3-dioxygenase --- inhibitor --- anti-tumor --- immune modulation --- tryptophan metabolism --- taxoids --- βIII-tubulin --- P-glycoprotein --- drug resistance --- thiopene --- thienopyrimidinone --- thiazolidinone --- breast cancer --- benzofuran–pyrazole --- nanoparticles --- cytotoxic activity --- PARP-1 inhibition --- 3,6-dibromocarbazole --- 5-bromoindole --- carbazole --- actin --- migration --- Thienopyrimidine --- Pyrazole --- PI3Kα inhibitor --- quinazolin-4(3H)-one --- quinazolin-4(3H)-thione --- Schiff base --- antioxidant activity --- DFT study --- ortho-quinones --- beta-lapachone --- tanshione IIA --- PI3Ks --- PI3Kδ inhibitors --- 2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide --- anticancer agents --- protein–protein interactions --- virtual screening --- mimetics --- drug discovery --- bivalency --- polyvalency --- antitumor --- cell cycle --- ovarian cancer --- P-MAPA --- IL-12 --- TLR signaling --- inflammation --- chemoresistance --- 4-(pyridin-4-yloxy)benzamide --- 1,2,3-triazole --- c-Met --- natural product --- anticancer agent --- zampanolide --- Talazoparib --- PARP inhibitor --- prodrug --- o-nitro-benzyl --- photoactivatable protecting groups --- salinomycin --- overcoming drug resistance --- tumor specificity --- synergy --- 5-fluorouracil --- gemcitabine --- amides/esters --- colchicine analogs --- thiocolchicine --- colchiceine --- antimitotic agents --- hydrates --- dihydropyranoindole --- HDAC inhibitors --- neuroblastoma --- aromatase --- MCF-7 --- NIH3T3 --- benzimidazole --- triazolothiadiazine --- docking --- ADME --- organosilicon compounds --- SILA-409 (Alis-409) --- SILA-421 (Alis-421) --- multidrug resistance (MDR) reversal --- ABCB1 (P-glycoprotein) --- colon cancer --- colchicine amide --- colchicine sulfonamide --- tubulin inhibitors --- docking studies --- crystal structure --- PROTACs --- protein degradation --- IGF-1R --- Src --- protein kinase --- phenylpyrazolopyrimidine --- enzyme inhibition --- molecular simulation --- androgen receptor --- prostate cancer --- enzalutamide --- apalutamide --- darolutamide --- triple-negative breast cancer --- cytotoxicity --- chrysin analogues --- flavonoid --- anticancer compounds